| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |